Skip to main content
Isomer
  1. Home
  2. Automated
  3. List of product information
  4. APO-NAPRO-NA TABLET 275 MG [SIN07136P]

APO-NAPRO-NA TABLET 275 MG [SIN07136P]

Active ingredients: APO-NAPRO-NA TABLET 275 MG

Last updated 26 October 2025

Product Info

APO-NAPRO-NA TABLET 275 MG

[SIN07136P]

Product information

Active Ingredient and Strength

NAPROXEN SODIUM - 275 MG

Dosage Form

TABLET, FILM COATED

Manufacturer and Country

APOTEX INC - CANADA

Registration Number

SIN07136P

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

M01AE02

Indications: For the relief of mild to moderately severe pain accompanied by inflammation in conditions such as musculoskeletal trauma and postdental extraction. Also indicated for the relief of pain associated with post partum cramping and dysmenorrhea.

Dosage: The recommended starting dose of naproxen sodium for adults is two 275 mg tablets followed by one 275 mg tablet every 6 to 8 hours, as required. The total daily dose should not exceed 5 tablets (1375 mg).

Contraindications: Peptic ulcer or active inflammatory diseases of the gastrointestinal system.
Known or suspected hypersensitivity to the drug. Naproxen sodium should not be used in patients in whom acute asthmatic attacks, urticaria, rhinitis or other allergic manifestations are precipitated by ASA or other nonsteroidal anti-inflammatory agents. Fatal anaphylactoid reactions have occurred in such individuals.